Cord lining-mesenchymal stem cells graft supplemented with an omental flap induces myocardial revascularization and ameliorates cardiac dysfunction in a rat model of chronic ischemic heart failure

Tissue Engineering - Part A

Volumn 19, Issue 11-12, 2013, Pages 1303-1315

  Lilyanna, Shera ^a   Martinez, Eliana C ^a   Vu, Thang D ^a   Ling, Lieng H ^b   Gan, Shu U ^a   Tan, Ai L ^a   Phan, Thang T ^a,c   Kofidis, Theo ^a,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Dept Medicine Endocrinol Diabet   (Singapore)

^c CellResearch Corp Pte Ltd   (Singapore)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; BLOOD VESSELS; CELL CULTURE; CELLS; ECHOCARDIOGRAPHY; RATS; REPAIR; TISSUE;

EJECTION FRACTION; ISCHEMIC INJURIES; MESENCHYMAL STEM CELL; MYOCARDIAL FUNCTION; MYOCARDIAL INFARCTION; REVASCULARIZATION; THERAPEUTIC INTERVENTION; TISSUE-ENGINEERED GRAFTS;

CARDIOLOGY;

RATTUS;

ANIMAL; ARTICLE; CELL SURVIVAL; CHRONIC DISEASE; CONFOCAL MICROSCOPY; CYTOLOGY; DISEASE MODEL; ECHOGRAPHY; HEART FAILURE; HEART FUNCTION TEST; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE; HEMODYNAMICS; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; OMENTUM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; RAT; SURGICAL FLAPS; UMBILICAL CORD;

ANIMALS; CELL SURVIVAL; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HEART FAILURE; HEART FUNCTION TESTS; HEART VENTRICLES; HEMODYNAMICS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICROSCOPY, CONFOCAL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; OMENTUM; PHENOTYPE; RATS; SURGICAL FLAPS; UMBILICAL CORD; VENTRICULAR FUNCTION, LEFT;

EID: 84876910668     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0407     Document Type: Article

References (50)

1. Lloyd-Jones, D., Adams, R.J., Brown, T.M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T.B., Ford, E., Furie, K., Gillespie, C., Go, A., Greenlund, K., Haase, N., Hailpern, S., Ho, P.M., Howard, V., Kissela, B., Kittner, S., Lackland, D., Lisabeth, L., Marelli, A., McDermott, M.M., Meigs, J., Mozaffarian, D., Mussolino, M., Nichol, G., Roger, V.L., Rosamond, W., Sacco, R., Sorlie, P., Stafford, R., Thom, T., Wasserthiel-Smoller, S., Wong, N.D., and Wylie-Rosett, J. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121, 948, 2010.
2. Roger, V.L., Weston, S.A., Gerber, Y., Killian, J.M., Dunlay, S.M., Jaffe, A.S., Bell, M.R., Kors, J., Yawn, B.P., and Jacobsen, S.J. Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation 121, 863, 2010.
3. Williams, A.R., and Hare, J.M. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 109, 923, 2011.
4. Martinez, E.C., and Kofidis, T. Adult stem cells for cardiac tissue engineering. J Mol Cell Cardiol 50, 312, 2011.
5. Kinnaird, T., Stabile, E., Burnett, M.S., Lee, C.W., Barr, S., Fuchs, S., and Epstein, S.E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94, 678, 2004.
6. Gnecchi, M., He, H., Liang, O.D., Melo, L.G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R.E., Ingwall, J.S., and Dzau, V.J. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11, 367, 2005.
7. Ohnishi, S., Yasuda, T., Kitamura, S., and Nagaya, N. Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells. Stem Cells 25, 1166, 2007.
8. Yoon, Y.S., Wecker, A., Heyd, L., Park, J.S., Tkebuchava, T., Kusano, K., Hanley, A., Scadova, H., Qin, G., Cha, D.H., Johnson, K.L., Aikawa, R., Asahara, T., and Losordo, D.W. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115, 326, 2005.
9. Khan, M., Mohsin, S., Khan, S.N., and Riazuddin, S. Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice. J Cell Mol Med 15, 1515, 2011.
10. Lee, E.J., Park, S.J., Kang, S.K., Kim, G.H., Kang, H.J., Lee, S.W., Jeon, H.B., and Kim, H.S. Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction. Mol Ther 20, 1424, 2012.
11. Deuse, T., Stubbendorff, M., Tang-Quan, K., Phillips, N., Kay, M.A., Eiermann, T., Phan, T.T., Volk, H.D., Reichenspurner, H., Robbins, R.C., and Schrepfer, S. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 20, 655, 2011.
12. OShaughnessy, L. Surgical treatment of cardiac ischemia. Lancet 232, 185, 1937.
13. Zhou, Q., Zhou, J.Y., Zheng, Z., Zhang, H., and Hu, S.S. A novel vascularized patch enhances cell survival and modifies ventricular remodeling in a rat myocardial infarction model. J Thorac Cardiovasc Surg 140, 1388.e1-3, 2010.
14. Ueyama, K., Bing, G., Tabata, Y., Ozeki, M., Doi, K., Nishimura, K., Suma, H., and Komeda, M. Development of biologic coronary artery bypass grafting in a rabbit model: revival of a classic concept with modern biotechnology. J Thorac Cardiovasc Surg 127, 1608, 2004.
15. Dvir, T., Kedem, A., Ruvinov, E., Levy, O., Freeman, I., Landa, N., Holbova, R., Feinberg, M.S., Dror, S., Etzion, Y., Leor, J., and Cohen, S. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci USA 106, 14990, 2009.
16. Suzuki, R., Hattori, F., Itabashi, Y., Yoshioka, M., Yuasa, S., Manabe-Kawaguchi, H., Murata, M., Makino, S., Kokaji, K., Yozu, R., and Fukuda, K. Omentopexy enhances graft function in myocardial cell sheet transplantation. Biochem Biophys Res Commun 387, 353, 2009.
17. Shudo, Y., Miyagawa, S., Fukushima, S., Saito, A., Shimizu, T., Okano, T., and Sawa, Y. Novel regenerative therapy using cell-sheet covered with omentum flap delivers a huge number of cells in a porcine myocardial infarction model. J Thorac Cardiovasc Surg 142, 1188, 2011.
18. Martinez, E.C., Wang, J., Lilyanna, S., Ling, L.H., Gan, S.U., Singh, R., Lee, C.N., and Kofidis, T. Post-ischaemic angiogenic therapy using in vivo prevascularized ascorbic acidenriched myocardial artificial grafts improves heart function in a rat model. J Tissue Eng Regen Med 2011 [Epub ahead of print];DOI: 10.1002/term.512.
19. Kanamori, T., Watanabe, G., Yasuda, T., Nagamine, H., Kamiya, H., and Koshida, Y. Hybrid surgical angiogenesis: omentopexy can enhance myocardial angiogenesis induced by cell therapy. Ann Thorac Surg 81, 160, 2006.
20. Weytjens, C., Cosyns, B., DHooge, J., Gallez, C., Droogmans, S., Lahoute, T., and Franken, P., Van Camp, G. Doppler myocardial imaging in adult male rats: reference values and reproducibility of velocity and deformation parameters. Eur J Echocardiogr 7, 411, 2006.
21. Martinez, E.C., Wang, J., Gan, S.U., Singh, R., Lee, C.N., and Kofidis, T. Ascorbic acid improves embryonic cardiomyoblast cell survival and promotes vascularization in potential myocardial grafts in vivo. Tissue Eng Part A 16, 1349, 2010.
22. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., and Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
23. Wu, X., Ren, J., and Li, J. Fibrin glue as the cell-delivery vehicle for mesenchymal stromal cells in regenerative medicine. Cytotherapy 14, 555, 2011.
24. Guo, H.D., Wang, H.J., Tan, Y.Z., and Wu, J.H. Transplantation of marrow-derived cardiac stem cells carried in fibrin improves cardiac function after myocardial infarction. Tissue Eng Part A 17, 45, 2011.
25. Tan, M.Y., Zhi, W., Wei, R.Q., Huang, Y.C., Zhou, K.P., Tan, B., Deng, L., Luo, J.C., Li, X.Q., Xie, H.Q., and Yang, Z.M. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 19, 3234, 2009.
26. Amado, L.C., Saliaris, A.P., Schuleri, K.H., St John, M., Xie, J.S., Cattaneo, S., Durand, D.J., Fitton, T., Kuang, J.Q., Stewart, G., Lehrke, S., Baumgartner, W.W., Martin, B.J., Heldman, A.W., and Hare, J.M. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102, 11474, 2005.
27. Quevedo, H.C., Hatzistergos, K.E., Oskouei, B.N., Feigenbaum, G.S., Rodriguez, J.E., Valdes, D., Pattany, P.M., Zambrano, J.P., Hu, Q., McNiece, I., Heldman, A.W., and Hare, J.M. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA 106, 14022, 2009.
28. Piao, H., Youn, T.J., Kwon, J.S., Kim, Y.H., Bae, J.W., Bora, S., Kim, D.W., Cho, M.C., and Lee, M.M., Park, Y.B. Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infarcting myocardium. Eur J Heart Fail 7, 730, 2005.
29. Toma, C., Pittenger, M.F., Cahill, K.S., Byrne, B.J., and Kessler, P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93, 2002.
30. Shinmura, D., Togashi, I., Miyoshi, S., Nishiyama, N., Hida, N., Tsuji, H., Tsuruta, H., Segawa, K., Tsukada, Y., Ogawa, S., and Umezawa, A. Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function. Stem Cells 29, 357, 2011.
31. Wang, T., Xu, Z., Jiang, W., and Ma, A. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol 109, 74, 2006.
32. Siegel, G., Krause, P., Wohrle, S., Nowak, P., Ayturan, M., Kluba, T., Brehm, B.R., Neumeister, B., Kohler, D., Rosenberger, P., Just, L., Northoff, H., and Schafer, R. Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential. Stem Cells Dev 21, 2457, 2012.
33. Grinnemo, K.H., Mansson, A., Dellgren, G., Klingberg, D., Wardell, E., Drvota, V., Tammik, C., Holgersson, J., Ringde ́n, O., Sylvén, C., and Le Blanc, K. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg 127, 1293, 2004.
34. Grinnemo, K.H., Mansson-Broberg, A., Leblanc, K., Corbascio, M., Wardell, E., Siddiqui, A.J., Hao, X., Sylven, C., and Dellgren, G. Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann Med 38, 144, 2006.
35. Jeschke, M.G., Gauglitz, G.G., Phan, T.T., Herndon, D.N., and Kita, K. Umbilical cord lining membrane and Whartons jelly-derived mesenchymal stem cells: the similarities and differences. Open Tissue Eng Regen Med J 4, 21, 2011.
36. Sivalingam, J., Krishnan, S., Ng, W.H., Lee, S.S., Phan, T.T., and Kon, O.L. Biosafety assessment of site-directed transgene integration in human umbilical cord-lining cells. Mol Ther 18, 1346, 2010.
37. Kita, K., Gauglitz, G.G., Phan, T.T., Herndon, D.N., and Jeschke, M.G. Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev 19, 491, 2010.
38. Martinez, E.C., and Kofidis, T. Myocardial tissue engineering: the quest for the ideal myocardial substitute. Expert Rev Cardiovasc Ther 7, 921, 2009.
39. Cortes-Morichetti, M., Frati, G., Schussler, O., Duong Van Huyen, J.P., Lauret, E., Genovese, J.A., Carpentier, A.F., and Chachques, J.C. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng 13, 2681, 2007.
40. Zimmermann, W-H. Tissue engineered myocardium. In: Boccaccini, A.R., and Harding, S.E., eds. Myocardial Tissue Engineering. Series: Studies in Mechanobiology, Tissue Engineering and Biomaterials. Berlin, Germany: Springer, 2011, pp. 111-132.
41. Simpson, D., Liu, H., Fan, T.H., Nerem, R., and Dudley, S.C., Jr. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells 25, 2350, 2007.
42. Zhang, H., Song, P., Tang, Y., Zhang, X.L., Zhao, S.H., Wei, Y.J., and Hu, S.S. Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: heart status and cell distribution. J Thorac Cardiovasc Surg 134, 1234, 2007.
43. Halkos, M.E., Zhao, Z.Q., Kerendi, F., Wang, N.P., Jiang, R., Schmarkey, L.S., Martin, B.J., Quyyumi, A.A., Few, W.L., Kin, H., Guyton, R.A., and Vinten-Johansen, J. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res Cardiol 103, 525, 2008.
44. Gnecchi, M., Zhang, Z., Ni, A., and Dzau, V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103, 1204, 2008.
45. Kinnaird, T., Stabile, E., Burnett, M.S., Shou, M., Lee, C.W., Barr, S., Fuchs, S., and Epstein, S.E. Local delivery of marrowderived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109, 1543, 2004.
46. Ohnishi, S., Sumiyoshi, H., Kitamura, S., and Nagaya, N. Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett 581, 3961, 2007.
47. Bourahla, B., Shafy, A., Meilhac, O., Elmadbouh, I., Michel, J.B., and Chachques, J.C. Mesothelial cells vs. skeletal myoblasts for myocardial infarction. Asian Cardiovasc Thorac Ann 18, 153, 2010.
48. van der Spoel, T.I., Jansen Lorkeers, S.J., Agostoni, P., van Belle, E., Gyongyosi, M., Sluijter, J.P., Cramer, M.J., Doevendans, P.A., and Chamuleau, S.A. Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. Cardiovasc Res 91, 649, 2011.
49. Bieback, K., Kern, S., Kluter, H., and Eichler, H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22, 625, 2004.
50. Bayes-Genis, A., Galvez-Monton, C., Prat-Vidal, C., and Soler-Botija, C. Cardiac adipose tissue: a new frontier for cardiac regeneration? Int J Cardiol 2012 [Epub ahead of print];DOI: 10.1016/j.ijcard.2012.05.082.